Epitopea ApS
CVR 45664872 · Private limited company (ApS) · Active · Medium risk
Epitopea ApS is a Private limited company (ApS), founded on , based in Klampenborg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 1 annual report has been published. The latest annual report (30 Apr 2026) shows equity of DKK -8.7m and a net result of DKK -8.7m. CEO: Klaus Edvardsen.
Bankruptcy risk for Epitopea ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45664872
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Klampenborgvej 26
2930 Klampenborg - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 20k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -321.3% |
| Current ratio | 24% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 |
|---|---|
| Gross profit | DKK -1.4m |
| Net profit | DKK -8.7m |
| Equity | DKK -8.7m |
| Total assets | DKK 2.7m |
| Cash | DKK 2.6m |
| Short-term debt | DKK 11.4m |
| Avg. employees | 0 |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 5 Jun 2025 – 30 Apr 2026 | 132 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Klaus Edvardsen | Current | |
| Owner (100%) | Epitopea Limited | Current | |
| Founder | Epitopea Limited | Current |
The CEOs' other companies
Klaus Edvardsen – 3 other companies
- ANGIO ApS Active
- AZANTA A/S Active
- IPC PHARMA A/S Opløst
Address history (0 moves)
| Klampenborgvej 26, 2930 Klampenborg |
Other companies at the same address
- Detgodeselskab ApS Bankrupt
- Detgodeselskab Holding ApS Bankrupt
- ANGIO ApS Active
Similar companies in Gentofte
- Lica Pharma ApS Hellerup
- SKN computation ApS Gentofte
- WinQure Medicine ApS Klampenborg
- Illum Biotech ApS Charlottenlund
- Novo Nordisk Clinical Innovation Centre A/S Gentofte
- Bollværk ApS Hellerup
- Spectoceutics ApS Gentofte
- CENEXUM Technologies ApS Gentofte
- Protein Frontiers ApS Gentofte
- ClinOption ApS Dyssegård
- Ascendis Pharma Oncology Division A/S Hellerup
- Merian Life Sciences ApS Hellerup
Questions and answers about Epitopea ApS
Has Epitopea ApS gone bankrupt?
No, Epitopea ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Epitopea ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Epitopea ApS?
Klaus Edvardsen is the CEO of Epitopea ApS.
When was Epitopea ApS founded?
Epitopea ApS was founded on 5 June 2025.
What is the equity of Epitopea ApS?
Equity was DKK -8.7m according to the annual report for the period ending 30 April 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.